Almirall (LBTSF) News Today $13.36 0.00 (0.00%) As of 09/12/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock LBTSF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period 3 Global Stocks Estimated To Be Trading Below Fair Value In May 2025May 22, 2025 | finance.yahoo.comAlmiralll, S.A. (LBTSF) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comAlmirall Q1 profit, sales beat forecasts; guidance held on drug momentumMay 12, 2025 | investing.comAlmirall Q1 2025 ResultsMay 12, 2025 | finance.yahoo.comAlmirall Technology Operations Company Profile 2025 - Insights of Digital Transformation Strategies and Innovation ProgramsMarch 31, 2025 | finance.yahoo.comJefferies Keeps Their Buy Rating on Almirall (0O9B)March 12, 2025 | markets.businessinsider.comKepler Capital Reaffirms Their Buy Rating on Almirall (0O9B)February 26, 2025 | markets.businessinsider.comSpain's Almirall expects to double revenue by 2030, CEO saysFebruary 26, 2025 | msn.comAlmirall (0O9B) Gets a Buy from RBC CapitalFebruary 25, 2025 | markets.businessinsider.comAlmiralll, S.A. (LBTSF) Q4 2024 Earnings Call TranscriptFebruary 25, 2025 | seekingalpha.comAlmirall at the JPMorgan Conference - Entering a New Era of Sustained GrowthJanuary 14, 2025 | finance.yahoo.comRBC Capital Reaffirms Their Buy Rating on Almirall (0O9B)December 13, 2024 | markets.businessinsider.comAlmirall Launches The Hive, Creating a Novel Collaborative Innovation Hub to Advance Life Sciences and HealthcareDecember 4, 2024 | finance.yahoo.comAlmirall, S.A. (LBTSF) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | seekingalpha.comAlmirall to Present 9-Month 2024 Financial ResultsNovember 11, 2024 | markets.businessinsider.comAlmirall completes EU regulatory procedure for antifungal JubliaOctober 15, 2024 | finance.yahoo.comAlmirall Announces Completion of Decentralized Regulatory Approval Procedure for Efinaconazole in EuropeOctober 15, 2024 | finance.yahoo.comAlmirall (0O9B) Gets a Buy from Kepler CapitalSeptember 29, 2024 | markets.businessinsider.comAlmirall to Present New Data on Biologics for Psoriasis and Atopic Dermatitis and Celebrates 80 Years of Innovation at the EADV CongressSeptember 23, 2024 | finance.yahoo.comLBTSF Almirall, S.A.September 11, 2024 | seekingalpha.comAlmirall, S.A. (LBTSF)August 15, 2024 | finance.yahoo.comAlmirall Shares Rise After Confirmed Targets, Revenue IncreaseMay 13, 2024 | marketwatch.comAlmirall, S.A. reports FY resultsFebruary 20, 2024 | msn.comAlmirall continues its progress to leadership in Medical Dermatology driven by strong growth in the European Dermatology businessFebruary 19, 2024 | finance.yahoo.comAlmirall and Microsoft partner on AI-powered drug discovery in dermatologyFebruary 5, 2024 | msn.comAlmirall, Etherna Team Up to Develop MRNA-Based Dermatology TherapiesDecember 12, 2023 | marketwatch.comAlmirall and etherna Enter Into a Multi-Target Alliance to Develop mRNA-based Therapies in Medical DermatologyDecember 12, 2023 | finance.yahoo.comAlmirall Shares Rise on European Approval for Skin DrugNovember 17, 2023 | marketwatch.comAlmirall Receives European Commission Approval of EBGLYSS® (lebrikizumab) for Moderate-to-Severe Atopic DermatitisNovember 17, 2023 | finance.yahoo.comAlmirall and Absci partner on AI-driven dermatological drug developmentNovember 15, 2023 | msn.comAbsci Corporation: Almirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseasesNovember 14, 2023 | finanznachrichten.deAlmirall and Absci announce AI drug discovery partnership to rapidly develop novel treatments for dermatological diseasesNovember 14, 2023 | finance.yahoo.comAbsci, Almirall partner on dermatologic drug developmentNovember 14, 2023 | msn.comAlmirall, S.A. reports 9M resultsNovember 9, 2023 | msn.comAlmirall’s Nine-month 2023 Results:November 9, 2023 | businesswire.comAlmirall's Lebrikizumab Improves Signs and Symptoms of Moderate-to-Severe Atopic Dermatitis (AD) in Patients Inadequately Controlled With or Ineligible for CyclosporineOctober 13, 2023 | businesswire.comAlmirall and EpimAb partner to develop bispecific antibody therapiesOctober 12, 2023 | msn.comEpimAb Biotherapeutics and Almirall Announce Bispecific Antibody License AgreementOctober 12, 2023 | businesswire.comAlmirall's Ilumetri® (tildrakizumab) Significantly Improves Wellbeing for Patients1 and Their Relatives2 in Moderate-to-Severe Plaque PsoriasisOctober 11, 2023 | finance.yahoo.comCentrient Pharmaceuticals joins Almirall’s growing innovation hub in BarcelonaOctober 10, 2023 | businesswire.comEMA’s CHMP supports Almirall’s Ebyglyss for atopic dermatitisSeptember 18, 2023 | msn.comAlmirall, S.A. reports 1H resultsJuly 24, 2023 | msn.comAlmirall: Ilumetri® (tildrakizumab) significantly improved the wellbeing of patients with moderate-to-severe plaque psoriasisJuly 7, 2023 | finance.yahoo.comAlmirall announces the pricing and closing of its €200mm non pre-emptive share capital increaseJune 13, 2023 | finance.yahoo.comAlmirall's Q1 core earnings beat estimates on Europe dermatology operationsMay 8, 2023 | news.yahoo.comAlmirall's core earnings beat estimates in Q1May 8, 2023 | reuters.comAlmirall’s First Quarter 2023 ResultsMay 8, 2023 | finance.yahoo.comAlmirall: Up to 73% of Atopic Dermatitis Patients Taking Lebrikizumab Had Improved or Cleared Skin on Face or Hands in New AnalysisMay 1, 2023 | finance.yahoo.comCREDIT SUISSE - EUROPE Maintains Almirall (XMAD:ALM) Neutral RecommendationApril 21, 2023 | msn.comAlmirall, S.A. (ALM.MC)April 13, 2023 | finance.yahoo.com Get Almirall News Delivered to You Automatically Sign up to receive the latest news and ratings for LBTSF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LBTSF Media Mentions By Week LBTSF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LBTSF News Sentiment▼0.000.93▲Average Medical News Sentiment LBTSF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LBTSF Articles This Week▼00▲LBTSF Articles Average Week Get the Latest News and Ratings for LBTSF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Almirall and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies TGIFF News FFNTF News ABSCF News AZFL News ERBB News AVTBF News AVCNF News BIOYF News CBGL News NUGS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:LBTSF) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredApple’s falling behindApple just posted record-breaking results, yet its stock barely moved — because in today’s market, investors o...Porter & Company | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone thought he was insane…SpaceX just struck a $17 billion deal with EchoStar for radio frequencies, and tech analyst Jeff Brown says it...Brownstone Research | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Almirall, S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Almirall With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LBTSF Stock Alerts